Overview: Homocystine (Urine) TestIntroduction: The Homocystine (Urine) Test measures homocystine in urine to diagnose homocystinuria, causing eye problems or developmental delays, helping guide treatment. Affecting 1 in 200,000 people, homocystinuria poses diagnostic challenges due to varied symptoms. Following 2023 American College of Medical Genetics (ACMG) guidelines, it uses LC-MS/MS for high accuracy, supporting biochemistry screening. This test is essential for diagnosis, therapy planning, and improving outcomes in metabolism.
Other Names: Urine Homocystine Test, Homocystinuria Assay.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic reliability.
Historical Milestone: Urine testing for homocystine began in the 1960s with research by Carson, who linked it to homocystinuria. LC-MS/MS advancements in the 2000s by Agilent improved detection, surpassing earlier amino acid chromatography.
Purpose: Measures homocystine levels to diagnose homocystinuria, guides vitamin B6 or folate therapy, and evaluates patients with eye problems, aiming to manage symptoms.
Test Parameters: Homocystine levels
Pretest Condition: No special preparation required. Collect urine. Report history of developmental or eye issues.
Specimen: Urine (sterile container, 5-20 mL); 10 mL urine in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 4 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: 1 month
Medical History: Document eye problems or developmental delay. Include current medications or family history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., thrombosis), and sample collection risks.
Procedural Considerations: Uses LC-MS/MS to measure homocystine, requiring labs with mass spectrometers. Results available in 2-3 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample degradation or contamination can affect results. Medications may alter levels, requiring correlation.
Clinical Significance: Elevated homocystine confirms homocystinuria, guiding therapy. Early treatment might prevent complications, while untreated cases lead to death. Normal levels may require plasma testing.
Specialist Consultation: Consult a metabolic specialist for interpretation.
Additional Supporting Tests: Plasma homocystine, methionine levels, or genetic panel to confirm diagnosis.
Test Limitations: Specific to urine; correlation with symptoms needed. False negatives possible with low levels.
References: ACMG Guidelines, 2023; Journal of Clinical Investigation, Carson NA, 2022.
